Related references
Note: Only part of the references are listed.SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Michael A. Johansson et al.
JAMA NETWORK OPEN (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
Mark W. Tenforde et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
Ivan Martinez-Baz et al.
EUROSURVEILLANCE (2021)
Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16
Clara Mazagatos et al.
PLOS ONE (2018)
Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany
Cornelius Remschmidt et al.
BMC INFECTIOUS DISEASES (2015)